Tapering Antipsychotic Treatment

This Viewpoint discusses principles for tapering antipsychotic treatment when deprescribing them.

Loading next page...

Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?

Murray, RM; Quattrone, D; Natesan, S
Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment

Viguera, AC; Baldessarini, RJ; Hegarty, JD; van Kammen, DP; Tohen, M
The nature of dopamine dysfunction in schizophrenia and what this means for treatment: meta-analysis of imaging studies

Howes, OD; Kambeitz, J; Kim, E
D2 but not D3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: influence of withdrawal period

Joyce, JN
Comparing rat’s to human’s age: how old is my rat in people years?

Quinn, R
Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis

Leucht, S; Tardy, M; Komossa, K
Estimating dopamine D2 receptor occupancy for doses of 8 antipsychotics: a meta-analysis

Lako, IM; van den Heuvel, ER; Knegtering, H; Bruggeman, R; Taxis, K
Dose-response meta-analysis of antipsychotic drugs for acute schizophrenia

Leucht, S; Crippa, A; Siafis, S; Patel, MX; Orsini, N; Davis, JM
Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial

Huhn, M; Leucht, C; Rothe, P
Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome

Wunderink, L; Nienhuis, FJ; Sytema, S; Slooff, CJ; Knegtering, R; Wiersma, D